Open Access
| Issue |
BIO Web Conf.
Volume 182, 2025
The 3rd International Conference on Food Science and Bio-medicine (ICFSB 2025)
|
|
|---|---|---|
| Article Number | 02005 | |
| Number of page(s) | 5 | |
| Section | Biomedical Research and Applications | |
| DOI | https://doi.org/10.1051/bioconf/202518202005 | |
| Published online | 02 July 2025 | |
- Prifti GM, Moianos D, Giannakopoulou E, et al. Recent Advances in Hepatitis B Treatment. Pharmaceuticals. 2021 May 1;14(5):417. doi: 10.3390/ph14050417. [Google Scholar]
- Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023 Aug; 20(8): 524–537. doi: 10.1038/s41575-023-00760-9. [Google Scholar]
- Lee HW, Lee JS, Ahn SH. Hepatitis B Virus Cure: Targets and Future Therapies. Int J Mol Sci. 2020 Dec 28;22(1):213. doi: 10.3390/ijms22010213. [Google Scholar]
- Saco TV, Strauss AT, Ledford DK. Hepatitis B vaccine nonresponders: Possible mechanisms and solutions. Ann Allergy Asthma Immunol. 2018 Sep; 121(3):320–327. doi: 10.1016/j.anai.2018.03.017. [CrossRef] [PubMed] [Google Scholar]
- Glebe D, Bremer CM. The molecular virology of hepatitis B virus. Semin Liver Dis. 2013 May; 33(2): 103–12. doi: 10.1055/s-0033-1345717. [Google Scholar]
- Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral Res. 2020 Oct;182:104925. doi: 10.1016/j.antiviral.2020.104925. [CrossRef] [PubMed] [Google Scholar]
- Ueda K, Tsurimoto T, Matsubara K. Three envelope proteins of hepatitis B virus: large S, middle S, and major S proteins needed for the formation of Dane particles. J Virol. 1991 Jul;65(7):3521–9. doi: 10.1128/JVI.65.7.3521-3529.1991. [Google Scholar]
- Karayiannis P. Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread. Hepatol Int. 2017 Nov; 11(6): 500–508. doi: 10.1007/s12072-017-9829-7. [Google Scholar]
- Ferrari C. HBV and the immune response. Liver Int. 2015 Jan;35 Suppl 1:121–8. doi: 10.1111/liv.12749. [Google Scholar]
- Fung J, Lai CL, Seto WK, et al. Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. J Antimicrob Chemother. 2011 Dec;66(12):2715–25. doi: 10.1093/jac/dkr388. [Google Scholar]
- Br VK, Sarin SK. Acute-on-chronic liver failure: Terminology, mechanisms and management. Clin Mol Hepatol. 2023 Jul;29(3):670–689. doi: 10.3350/cmh.2022.0103. [CrossRef] [PubMed] [Google Scholar]
- Cao J, Zhang J, Lu Y, et al. Cryo-EM structure of native spherical subviral particles isolated from HBV carriers. Virus Res. 2019 Jan 2;259:90–96. doi: 10.1016/j.virusres.2018.10.015. [Google Scholar]
- Gish, R.G., Basit, S.A., Ryan, J. et al. Hepatitis B Core Antibody: Role in Clinical Practice in 2020. Curr Hepatology Rep 19, 254–265 (2020). doi.org/10.1007/s11901-020-00522-0. [Google Scholar]
- Gerlich WH. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol. 2015 Feb; 204(1): 39–55. doi: 10.1007/s00430-014-0373-y. [Google Scholar]
- Shi S, Zhu H, Xia X, et al. Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity. Vaccine. 2019 May 27; 37(24): 3167–3178. doi: 10.1016/j.vaccine.2019.04.055. [Google Scholar]
- Yang S, Tian G, Cui Y, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep. 2016 Jun 21;6:27251. doi: 10.1038/srep27251. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.